HomeCompareMCURF vs GBDC

MCURF vs GBDC: Dividend Comparison 2026

MCURF yields 394.48% · GBDC yields 11.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MCURF wins by $10312.07M in total portfolio value
10 years
MCURF
MCURF
● Live price
394.48%
Share price
$0.51
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$10332.85M
Annual income
$6,894,665,125.52
Full MCURF calculator →
GBDC
GBDC
● Live price
11.85%
Share price
$12.66
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.78M
Annual income
$16,389,263.41
Full GBDC calculator →

Portfolio growth — MCURF vs GBDC

📍 MCURF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMCURFGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MCURF + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MCURF pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MCURF
Annual income on $10K today (after 15% tax)
$33,530.57/yr
After 10yr DRIP, annual income (after tax)
$5,860,465,356.69/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.11/yr
After 10yr DRIP, annual income (after tax)
$13,930,873.90/yr
At 15% tax rate, MCURF beats the other by $5,846,534,482.79/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MCURF + GBDC for your $10,000?

MCURF: 50%GBDC: 50%
100% GBDC50/50100% MCURF
Portfolio after 10yr
$5176.81M
Annual income
$3,455,527,194.46/yr
Blended yield
66.75%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

MCURF
No analyst data
Altman Z
720.6
Piotroski
2/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.6% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MCURF buys
0
GBDC buys
2
PoliticianChamberTickerTypeAmountDate
David P. Joyce🏢 House$GBDC▼ Sell$1,001 - $15,0002023-06-30
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002023-06-19
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002022-07-14
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002022-07-12
Teresa Leger Fernandez🏢 House$GBDC▼ Sell$15,001 - $50,0002021-01-20
David P. Joyce🏢 House$GBDC▲ Buy$1,001 - $15,0002020-02-25
David P. Joyce🏢 House$GBDC▲ Buy$15,001 - $50,0002019-05-30
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMCURFGBDC
Forward yield394.48%11.85%
Annual dividend / share$2.00$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1%
Portfolio after 10y$10332.85M$20.78M
Annual income after 10y$6,894,665,125.52$16,389,263.41
Total dividends collected$10015.27M$20.36M
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: MCURF vs GBDC ($10,000, DRIP)

YearMCURF PortfolioMCURF Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$50,148$39,447.73$12,490$1,790.28+$37.7KMCURF
2$238,538$184,879.84$16,522$3,157.73+$222.0KMCURF
3$1,077,122$821,886.59$23,578$5,898.68+$1.05MMCURF
4$4,620,972$3,468,451.78$37,115$11,886.75+$4.58MMCURF
5$18,851,020$13,906,579.02$66,136$26,423.57+$18.78MMCURF
6$73,190,380$53,019,788.68$137,257$66,491.44+$73.05MMCURF
7$270,699,664$192,385,957.90$341,734$194,868.54+$270.36MMCURF
8$954,651,189$665,002,548.15$1,050,788$685,133.02+$953.60MMCURF
9$3,213,254,616$2,191,777,844.33$4,099,314$2,974,971.01+$3209.16MMCURF
10$10,332,847,565$6,894,665,125.52$20,775,530$16,389,263.41+$10312.07MMCURF

MCURF vs GBDC: Complete Analysis 2026

MCURFStock

Mind Cure Health Inc., a life sciences company, develops and commercializes mental health and wellness products in North America. It focuses on the development of digital therapeutics technology and researching psychedelic compounds to rapidly scale science-backed and evidence-based mental health therapy. The company develops iSTRYM, a digital therapeutics tool and first-of-its-kind software application that optimizes the healing journey for patients and clinicians before, during, and after therapy sessions; PsyCollage, a bioinformatics platform that helps to drive research by identifying priority research programs; synthetic ibogaine to supply researchers and clinicians; and psychedelic compounds, including ibogaine for traumatic brain injuries and related conditions. Mind Cure Health Inc. was incorporated in 2020 and is headquartered in Vancouver, Canada.

Full MCURF Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this MCURF vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MCURF vs SCHDMCURF vs JEPIMCURF vs OMCURF vs KOMCURF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.